chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the first dose of the Moderna vaccine on September 21,2021 and noticed a small rash/welt on my left upper forearm on October 7,2021. I also experienced other symptoms such as fever, dizziness, fatigue, headache, muscle and body aches within 24 hours. When I received the second dose of the Moderna vaccine on October 22,2021 I started developing a skin reaction: rash, hives, and itching, on Tuesday October 26,2021. It started on my left arm, and then spread all across my chest, stomach, back, hip, butt and upper legs front and back. It has been continuously itching and does not seem to be clearing up. As of today November 5,2021 the rash is still in all the same places that were mentioned before, but it has now spread to my neck, face, head, and inside of my ear. ?
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 (lot # L019836, expiration date 24-MAR-2017; lot # M022085, expiration date 09-OCT-2017, dose and route not reported). The doses of vaccine were improperly stored at 1.7 Celsius degree for 32 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a nurse concerning a pt who on 06Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5ml), IM (lot 649981/0704P or 650451/0750P). On 07Sep05 the pt complained of hard firm area at site with swelling and more swelling at the elbow than the vaccination site. Ice was prescribed to area and acetaminophen (Tylenol). The nurse stated that the pt had improved. Additional information has been requested.
pt appeared to have fainted in lobby-fell flat on face-when mom picked pt up pt was stiff, eyes rolled top of head-out only a few seconds;nurse called;pt awake talking, skin warm dry;dime size bruise on chin, chalk lip;
Fever, chills, and overly tired from around 11:00pm on April 22 until around the early hours of the morning on April 24. Fever broke while asleep, but had to have been between 1:00am and 6:00am. At its highest (measured) point, the fever was 100.3 degrees. My normal body temperature floats somewhere between 96 and 97 degrees.
blood clots; Shortness of breath when walking upstairs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (blood clots) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (blood clots) (seriousness criterion medically significant) and DYSPNOEA (Shortness of breath when walking upstairs). At the time of the report, THROMBOSIS (blood clots) and DYSPNOEA (Shortness of breath when walking upstairs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.  Very limited information regarding this event has been provided at this time.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time.
Headache, Sedation, Myalgia, Arthralgia, Fever, CoughWheeze, Rash, Chills, dyspnea, Occipital headache extending down neck. Arms and legs felt heavy. Injection site with warmth, swelling and erythema.
Patient contracted VARICELLA.  Patient had body rash diagnosed as VARICELLA 3/1/10 after receiving both doses of VARICELLA vaccination.
Severe stabbing pain in my right foot; Moderate to severe pain in my right ankle; This case was reported by a consumer via interactive digital media and described the occurrence of foot pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st April 2022, the patient received the 1st dose of Shingrix. On 2nd April 2022, 1 days after receiving Shingrix, the patient experienced foot pain and pain ankle. The patient was treated with morphine. On 2nd April 2022, the outcome of the foot pain was recovered/resolved. On an unknown date, the outcome of the pain ankle was not recovered/not resolved.   It was unknown if the reporter considered the foot pain and pain ankle to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-APR-2022 Reporter's Comments: This case was reported by patient via interactive digital media. The patient received dose of Shingrix vaccine and went to the ER (Emergency Room Visit) with severe stabbing pain in his/her right foot.  The patient was given morphine which did help and by 2nd April 2022 the foot pain was gone, but he/she continued to had moderate to severe pain in his/her right ankle. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Had high fever up to 102.3F, severe body aches making it difficult to sleep or function, and general fatigue starting about 12 hours after vaccination and lasting until about 45 hours after the vaccination. I previously had Covid in November 2019.
Patient was administered below vaccines and about 1 minute later patient started to say she was "dizzy" & slowing losing her balance. Patient was caught and attended by provider and was back to normal state in about 30min. Patient prior to vaccines was scared & nervous. Patient also had not ate.
A week after (1/6/21) the injection the injection the site became itchy.  The next morning (1/7/21) the right arm developed a red area raised  in the shape of a square. It was itchy, hot , hard and sore. After Motrin the symptoms improved but was still there. Symptoms persisted until 1/10/21.  On 1/11/21 the redness was traveling down her upper arm and was hot.  At the moment it is still red and hot but is not painful.
No adverse event; 24 year old male patient who never received a primary series with monovalent formulation was given bivalent booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (24 year old male patient who never received a primary series with monovalent formulation was given bivalent booster dose) and NO ADVERSE EVENT (No adverse event) in a 24-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Feb-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Feb-2023, the patient experienced WRONG PRODUCT ADMINISTERED (24 year old male patient who never received a primary series with monovalent formulation was given bivalent booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (24 year old male patient who never received a primary series with monovalent formulation was given bivalent booster dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (24 year old male patient who never received a primary series with monovalent formulation was given bivalent booster dose).    Concomitant medication of the patient was not reported.  The patient never received a primary series with monovalent formulation and was given bivalent booster dose.  Treatment information was not provided by the reporter.
Fever; chills; body aches; headache; fatigue for 2 days.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 03-FEB-2015, the patient was vaccinated with M-M-R II (lot number: K002816 with unspecified expiration date) (dose, frequency and route unspecified) that had underwent temperature excursion. Concomitant medications were not reported. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with M-M-R II was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.
Beginning two days after receiving dose 2 of Moderna, patient developed numbness in the arm in which the vaccine was administered.  Numbness reached from deltoid to fingertip.  Since this time, the numbness has continued to worsen, precipitating a clinic visit and treatment with prednisone, ibuprofen, and gabapentin.
About 15 minutes after the injection I felt light headed and my chronic back pain was completely gone. Around 5 hours after injection I was overcome with extreme lethargy and had to sleep. 8 hours after injection I woke up very nauseous and could not stop salivating, however I never puked. I woke up again 18 hours after injection and felt nauseous and my chronic back pain had returned. I also had a weird throbbing pain in the right side of my neck and in the lower left side of my left leg. All symptoms were gone by ~36 hours after the injection.
On Sept. 28 in the morning, I started to show signs of mild facial paralysis on the left side, mainly the mouth. By the afternoon, I noticed my left eye looked "off". On  Sept. 29, I went to the Emergency Room and was diagnosed with Bell's Palsy.
Principal Dx/ Final Dx: AKI (acute kidney injury)   Relevant Inpt Dx: Principal Problem:   AKI (acute kidney injury) Active Problems:   COVID-19 virus infection   Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin   Essential hypertension       HPI:   Hospital Course:   This elderly man was admitted with acute kidney injury.  He had recently been in hospital with covid.  He was given ivf and he is doing well.  He is eating better and his creatinine is near normal.  Follow up with pcp.           Consults:   None       Disposition:  home   Discharge Condition:  fair
Lymph nodes in left armpit are enlarged and are causing extreme tenderness and soreness. Getting worse each day and skin all down the arm, down torso and across chest is sensitive.
Pt recvd MMR vax on 15MAY90; On 29MAY90 devel generalized maculopapular rash, temp greater than or equal to 102, lymphadenopathy & myalgia; Resp viral panel was neg; Pt recovered;
swollen eyes & eye discomfort, petechial rashes persistent 3 months after 1st vaccine, L axilla swelling & discomfort
new onset afib found at medical facility 6/7/21  patient had been c/o feeling sob and with fatigue x 1 month- presented to medical facility- found to have pedal edema and new onset afib
Patient reports tender, swollen lymph nodes on same side of body as the vaccine in the armpit region beginning approximately 2-3 days post administration.
Lower back pain; Muscle and joint pain.; Muscle and joint pain.; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain), MYALGIA (Muscle and joint pain.), ARTHRALGIA (Muscle and joint pain.) and FATIGUE (Fatigue) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007821A) for COVID-19 prophylaxis.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included METFORMIN for an unknown indication.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced BACK PAIN (Lower back pain), MYALGIA (Muscle and joint pain.), ARTHRALGIA (Muscle and joint pain.) and FATIGUE (Fatigue). At the time of the report, BACK PAIN (Lower back pain), MYALGIA (Muscle and joint pain.), ARTHRALGIA (Muscle and joint pain.) and FATIGUE (Fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jul-2021, Nasopharyngeal swab: (Negative) Negative.         No treatment medications were reported.  Since the vaccination, had the patient been tested for COVID-19?:Yes  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
Burning sensation; Sensitive skin; Does not feel the area unless something is touching the area; This case was reported by a consumer via call center representative and described the occurrence of burning sensation in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. In November 2019, between 1 and 2 weeks after receiving Shingrix, the patient experienced burning sensation, sensitive skin and numbness localized. On an unknown date, the outcome of the burning sensation was not recovered/not resolved and the outcome of the sensitive skin and numbness localized were unknown.   It was unknown if the reporter considered the burning sensation, sensitive skin and numbness localized to be related to Shingrix.  Additional case details were reported as follows: The patient reported for himself. The patient had the Shingrix vaccine in the right arm, approximately at the end of October 2019 or early part of November 2019. He did not know exact date. About 8 to 10 days before the reporting date, the patient developed sensitive skin about a quarter inch below his rib cage. The patient described it as, the area was about four inches wide and run horizontal. The area was a football shape cut in half that tapered to a point along the sides of his body. It was in the center of his rib cage area. The patient also stated that, he did not feel the area unless something touch it such as his shirt or sheet.  He described these symptoms as a burning sensation, the area was not red and did not itch. He further stated that, the sensation moved down his rib cage. The patient mentioned this to his physician but his physician did not know what it could be. The patient did not have lot number. The patient consented to follow up and provided his physician's details also.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies. The reporter stated that improperly stored doses of VARIVAX, Lot number M025865, expiration date 24-MAY-2018 and M010483, expiration date 01-MAR-2018 (dose, route, and anatomical location were not reported), were administered to an unspecified number of patients on unspecified dates since 19-OCT-2016, for prophylaxis. The vaccine was exposed to a temperature of 10.8 Fahrenheit (F) for 4 hours and 56 minutes due to a data logger issue.  There was no previous temperature excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of two reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1702USA001614:
This case was reported by a consumer and described the occurrence of runny nose in a 69-year-old patient who received FLULAVAL (batch number UNKNOWN, expiry date unknown). The patient's past medical history included diabetic and high cholesterol. Concomitant products included CRESTOR, NOVOLOG, lisinopril and metformin. On 25th October 2014 14:15, the patient received FLULAVAL (intramuscular). On an unknown date, the dose was an unknown dose. On 2nd November 2014, 8 days after receiving FLULAVAL, the patient experienced runny nose, ear noises, sore throat, cough and swollen glands. On an unknown date, the outcome of the runny nose, ear noises, sore throat, cough and swollen glands were not recovered/not resolved. It was unknown if the reporter considered the runny nose, ear noises, sore throat, cough and swollen glands to be related to FLULAVAL. Additional information: A 69 year old male patient received a FLULAVAL vaccine at his physician's office on October 25th, 2014. The patient reports that 8 to 10 days later he began to experience a runny nose and cough. The patient reports that his glands were swollen and that his ears felt full and needed to be popped by yawning. The patient reports that the symptoms have not gone away. At time of report, the patient noted that he saw his physician on January 5, 2015, and the physician prescribed a Z-PAK.
Rash with large raised dots. Originated on left arm, then patches occurred across abdomen, knees, and buttocks and both forearms. Persisted until present (4 weeks). Placed on prednisone taper for contact dermatitis, then when it continued to persist after two course of prednisone my doctor wondered if this is possibly an adverse event since symptoms continue unresolved.
Injection site redness and rash from the injection down my arm about 3.5 inches.  Very itchy at times
Patient reported to his mother Saturday afternoon that his armpit of the arm where he got shot was sore. It wasn't extremely painful, so she was not concerned. Unfortunately it was not better by this afternoon, so she called to ask me if that was a normal side effect. I asked her to look at the injection site to see if there was a reaction and she could barely see pinkness around the injection site. Then I asked her to look at his armpit to see if it was swollen or red. After comparing both of his armpits, she could tell that the one closest to the injection site looked raised, perhaps a swollen lymph node. I recommended she give ibuprofen and do warm compresses. If the soreness and or swelling continues, please contact his regular doctor.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient(pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. In 2016, the pt was inoculated with zoster vaccine live(ZOSTAVAX)(dose, route of administration, anatomical location, lot#, expiration date were unknown), as prescribed and/or administered by a pharmacist for the long-term prevention of shingles and zoster-related conditions. Subsequent to zoster vaccine live(ZOSTAVAX) inoculation, pt was treated for shingles. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Hives; lips really swollen; woke up with an allergic reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), LIP SWELLING (lips really swollen) and ALLERGY TO VACCINE (woke up with an allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced URTICARIA (Hives), LIP SWELLING (lips really swollen) and ALLERGY TO VACCINE (woke up with an allergic reaction). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 27-Mar-2021, URTICARIA (Hives) had resolved. On 29-Mar-2021, LIP SWELLING (lips really swollen) had resolved. At the time of the report, ALLERGY TO VACCINE (woke up with an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided.  Treatment for the event included Benadryl & steroids.
Pt has a history of feeling weak and passing out with previous dose of HPV9 vaccine and with getting blood drawn. Pt lied down on exam table prior to administration of vaccinations. A few minutes after administration of vaccines, pt c/o feeling weak, tired, hot and nauseated, pt became pale and diaphoretic. Vital signs monitored for 30 minutes, pt given water, candy and an ice pack applied to forehead and neck and then pt reported feeling better with vital signs returning to normal and color returned to face and lips within 30 minutes.
Pt recv vax on 3/15/99; on 3/22/99 pt exp red, sore, tender below vax site; tx=Emycin
Information has been received from a physician concerning an 8 month old white female patient who was vaccinated with a first, second and third oral dose of Rotateq on 28-JUL-2006 (Lot # 654504/0695F), 28-AUG-2006 (Lot # 654504/0695F), and 25-OCT-2006 (654665/1017F). the patient had no medical history, no known drug allergies and was not on any concomitant medication. On 17-NOV-2006 the patient was seen in the doctors office and was diagnosed with intussusception. The patient was admitted to hospital that same day, where she underwent emergency surgery. On 22-NOV-2006, the patient was discharged from the hospital. on 07-DEC-2007, the patient was seen in the doctors office for a well-visit and was considered recovered from the intussusception. There was no product quality complaint involved. Additional information has been requested.  3/22/07 Received medical records from hospital which reveal patient experienced intermittent abdominal pain associated w/vomiting approx 24 hours prior to admit on 11/17/06-11/22/06.  Seen by PCP who noted bloody stool & tender abdomen.  Barium enema performed at outlying facility but failed to reduce IS noted in mid transverse colon near splenic flexure.  Then transferred to higher level of care where air reduction enema was also unsuccessful.  Peds Surg consult obtained.  Taken to OR where ileocolic resection w/primary anastomosis was performed.  Progressed slowly but steadily, oral diet tolerated by d/c to home w/o further complication except for oral thrush which was treated. FINAL DX: Ileocecal intussusception w/necrotic bowel, surgically reduced w/bowel resection.
Information has been received from a pharmacist referring to a currently 60 year old male patient with high blood pressure. Information regarding concomitant medication and drug reactions/allergies was unknown. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot # M032139 with expiration date 02-OCT-2017, dose unknown, subcutaneous). It was reported that after the patient received the vaccine, he still experienced an outbreak of shingles (date unspecified) (vaccination failure). The patient didn't contact physician for medical attention. It was unknown if treatment was given for the events or if lab diagnostics studies were performed. The outcome of the events was unknown. The causality was not reported. Additional information has been requested.